SAM & Co. advises Jusmiral Holdings Ltd. on ~USD 350 Million ‘On-Market Sale’ of Shares in Cohance Lifesciences Ltd.
SAM has earlier advised Advent in its control acquisition of Suven Pharmaceuticals Limited by way of a share purchase and mandatory open offer.